Skip to main content
Back to General Catalyst

General Catalyst's Therapeutics Portfolio

Browse 16 Therapeutics companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
16
Total Funding in Therapeutics
$838.4M

Therapeutics Portfolio Companies (16)

Export
BiotechnologyHealth CareMedical DeviceTherapeutics

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Lexington, United States
September 2025
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.

Toronto, Canada
September 2024
$9.1M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMental HealthmHealthPersonal HealthTherapeuticsWellness

Mindstrong is a virtual mental health platform.

Menlo Park, United States
September 2022
$250K
Grant

Founder Contacts

30,000+ verified contacts

Health CareInsuranceMental HealthmHealthTelehealthTherapeuticsWellness

SonderMind is a mental healthcare provider that offers treatment for mental health through therapy and psychiatry.

Denver, United States
July 2021
$150.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMedicalmHealthTherapeutics

Sword Health offers AI-powered physical therapy solutions for pain recovery at home.

New York, United States
June 2025
$40.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$25.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMobile AppsTherapeutics

Thea is an AI-powered skincare and dermatology app that gives personalized skincare advice, product recommendations.

New York, United States
May 2026
$4.0M
Pre-Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalService IndustryTherapeutics

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.

San Diego, United States
April 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

South San Francisco, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Information TechnologyTherapeutics

Maxion Therapeutics helps in learning transformative therapies.

Cambridge, United Kingdom
March 2025
$75.3M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMental HealthmHealthTherapeuticsWellness

Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.

Cambridge, United States
August 2025
$35.2M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

South San Francisco, United States
August 2025
$30.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyTherapeutics

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Boston, United States
August 2024
$112.3M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Gaithersburg, United States
August 2023
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio